BNTX - BioNTech SE
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$130.25
DETAILS
HIGH:
$158.00
LOW:
$96.00
MEDIAN:
$131.50
CONSENSUS:
$130.25
UPSIDE:
40.89%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 77.6% |
| EBIT Margin | -36.1% |
| EBITDA Margin | -22.8% |
| Operating Margin | -22.6% |
| Pretax Margin | -36.6% |
| Cont. Ops Margin | -39.6% |
| Net Margin | -39.6% |
| Bottom Line Margin | -39.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.54 |
| Quick Ratio | 7.49 |
| Solvency Ratio | -0.262 |
| Cash Ratio | 3.58 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | -0.29 |
| Forward PEG | -0.29 |
| Price/Book | 1.02 |
| Price/Sales | 7.10 |
| Price/FCF | 72.58 |
| Price/Op Cash Flow | 44.71 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0122 |
| Debt/Equity | 0.0139 |
| Debt/Capital | 0.0137 |
| Long-Term Debt/Capital | 0.0016 |
| Financial Leverage | 1.14 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.18 |
| Operating Cash Flow Ratio | 0.205 |
| Operating Cash Flow/Sales | 15.9% |
| Free Cash Flow/Operating Cash Flow | 61.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -10.79 |
| Interest Coverage | -45.7394 |
| Short-Term Operating Cash Flow Coverage | 8.39 |
| Operating Cash Flow Coverage | 1.64 |
| Capital Expenditure Coverage | 2.60 |
| Dividend + Capital Expenditure Coverage | 2.60 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 11.41 |
| EPS | -4.515 |
| Debt/Share | 1.1623 |
| Cash/Share | 61.37 |
| Book Value/Share | 79.50 |
| Tangible BV/Share | 71.34 |
| Equity/Share | 79.50 |
| Operating Cash Flow/Share | 1.812 |
| Capital Expenditure/Share | 0.696 |
| FCF/Share | 1.116 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.081 |
| Earnings Before Tax/EBIT | 1.618 |
| Price/Fair Value | 1.02 |
| Debt/Market Cap | 0.0042 |
| Effective Tax Rate | -8.1% |
| Enterprise Value Multiple | -19.39 |